secwatch.observer — SEC 8-K summary
======================================

Issuer:     GYRE THERAPEUTICS, INC. (GYRE)
CIK:        0001124105
Form:       8-K
Filed at:   2021-10-13T23:59:59+00:00
Accession:  0001193125-21-297901
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catalyst Biosciences CFO Clinton Musil resigns; controller Seline Miller named interim CFO
--------------------------------------------------------------------------------

- Clinton Musil resigns as CFO effective Oct 29, 2021 for personal reasons; will provide consulting services.
- Seline Miller promoted to SVP Finance and named interim CFO and principal accounting officer.
- Miller's base salary increased to $300k (from $250k) and bonus target raised to 30% (from 25%).
- Company initiates search for a permanent CFO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1124105/000119312521297901/0001193125-21-297901-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1124105/000119312521297901/d230267d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-297901

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer